Is CLX stock overvalued right now?

CLX is trading near our fair value estimate of $79.79, within a normal valuation band.

What is CLX fair value based on current fundamentals?

Our fair value estimate for CLX is $79.79, derived from discounted cash flow, dividend discount, and relative valuation multiples. The estimate assumes a discount rate of 9.0% and terminal growth of 2.5%.

How risky is CLX compared with other stocks?

CLX carries a beta of 0.54 suggests a defensive profile. Investors should weigh macro exposure against their own risk tolerance.

Is CLX still growing?

Latest trailing metrics show revenue contraction of 2.0% and earnings contraction of 50.1%. Profit margins are 8.7%.

What do analysts think about CLX?

Analyst consensus target is $100.76, implying 12.8% upside. The street recommendation is "hold".

Does CLX pay a dividend?

Yes. CLX currently offers a dividend yield of 5.6%.

What could change the investment case for CLX?

Key catalysts include Consumer Defensive sector dynamics, interest rate shifts, and company-specific earnings surprises. Monitor macro risk scores and analyst estimate revisions for early signals.

Updated·Data: Yahoo Finance, SEC EDGAR·Data delayed ~5 min

Review CLX High Conviction Pick Partnership News result

NYQ · Consumer Defensive · Household & Personal Products

$89.31

+1.55 (+1.77%)

Stock valuation guide Macro risk explained guide

About the Author

Phasakorn Traklang (Peach) — Founder

Phasakorn Traklang (Peach) is the founder of QuantSoar, bringing expertise in SEO, web development, and technical analytics to build an AI-powered investment platform accessible to retail investors worldwide.

Connect on LinkedIn

Investment Disclaimer: QuantSoar is for informational purposes only. We do not provide personalized investment advice. Always conduct your own research or consult a financial advisor. SEC

Data: Yahoo Finance / SEC EDGAR / Alpha Vantage / Finnhub. AI outputs verified against source data.